Q3 2025 Earnings Call Transcript October 22, 2025 Lennox International Inc. beats earnings expectations. Reported EPS is ...

The Federal Office for Information Security stated that data phishing has become a part of digital life like videos and social networks, where fraudulent email senders often achieve their goal and spy ...

Strong net sales growth, well on track to achieve full year outlook (1) In Q3 2025, Nokia changed how it presents gains and losses from venture fund investments. The comparative financial information ...

Q2 2026 Earnings Call October 23, 2025 5:00 PM EDTCompany ParticipantsSarah LeeDaniel Shugar - Co-Founder, CEO ...

Good morning, and welcome to Ladder Capital Corp.'s Earnings Call for the Third Quarter of 2025. As a reminder, today's call is being recorded. This morning, Ladder released its financial results for ...

OSLO, Norway (23 October 2025) - TGS today reports interim financial results for Q3 2025. Recovery after weak second quarter - Q3 revenues of USD 388 million, a 26% sequential growth ...

EEST Nokia Corporation Interim Report for Q3 2025Strong net sales growth, well on track to achieve full year outlook Q3 comparable net sales ...

FLAMGP is already the platform for millions of users worldwide, with more than 60% of them coming from North America and Europe. It is pointed out by the analysts that the fast expansion of the ...

Strong commercial performance of Renault Group: In 2025 Q3, sales were up 9.8% vs. 2024 Q3 with 529,486 vehicles sold with international sales up 14.9% and European 2 sales up 7.5%. In the first 9 ...

The Indian skincare market is expanding, driven by e-commerce growth, rising disposable incomes, and increasing demand for natural products. Opportunities lie in Tier 2 and 3 cities and clean, vegan ...

Green! HEINEKEN unveils EverGreen 2030, its five-year strategy to accelerate growth Amsterdam, 23 October – HEINEKEN sees significant headroom for growth in the beer category, the company shall ...

Group sales In the first nine months of 2025, Roche achieved sales growth of 7% (2% in CHF) to CHF 45.9 billion due to strong demand for our pharmaceutical and diagnostic products.